Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Chinese official: Beijing should target goods needed by US

Sep 19, 2018

BEIJING — One of China's most prominent figures in global finance says Beijing should press Washington to end their tariff battle by clamping down on exports of goods needed by American companies, according to news reports Monday. The comments by Lou Jiwei, a former finance minister and chairman of China's sovereign wealth fund, follow reports regulators are squeezing American companies by slowing down customs approvals and stepping up environmental and other inspections. Also Monday, an official newspaper called for more aggressive measures to "make American pain worse" following tariff hikes by both sides on $50 billion of each other's goods....

World stocks rise on report of US-China trade talks

Sep 19, 2018

SINGAPORE — Many global markets climbed Thursday following a report that the U.S. has proposed a new round of trade negotiations with China before going ahead with plans to slap tariffs on $200 billion or more in Chinese goods. Investors also appeared heartened by an interest rate increase by Turkey that could help ease its currency crisis, while other major central banks in Europe held off major policy changes. KEEPING SCORE: In Europe, France's CAC 40 gained 0.4 percent to 5,354 while the DAX in Germany added 0.5 percent to 12,089. Britain's FTSE 100 dropped 0.2 percent to 7,296. Wall...

Asian stocks rise on possible US-China talks amid tensions

Sep 19, 2018

SINGAPORE — Asian markets were mostly higher on Thursday after a report that the U.S. had proposed a new round of trade negotiations with China quelled fears that a dispute between the world's two largest economies was spiraling out of control. KEEPING SCORE: Japan's benchmark Nikkei 225 added 0.8 percent to 22,787.33, and the Kospi in South Korea rose 0.1 percent to 2,284.74. Hong Kong's Hang Seng index jumped 1.4 percent to 26,711.07. The Shanghai Composite index gained 0.2 percent to 2,662.54. But Australia's S&P/ASX 200 shed 0.6 percent to 6,141.00. Stocks were higher in Taiwan and Southeast Asia. WALL...

US lawmakers urge export restrictions targeting Xinjiang

Sep 19, 2018

BEIJING — Two U.S. lawmakers are urging the extension of tougher American export restrictions to prevent sales of equipment that could be used in China's massive security clampdown targeting the Xinjiang region's native Muslim population. Sen. Marco Rubio and Rep. Chris Smith want foreign entities, including businesses, research institutions, government and private organizations, and individuals seen as profiting from the clampdown added to a watch list, the two Republicans, among the staunchest critics of China in the U.S. Congress, said in a letter Wednesday to Commerce Secretary Wilbur Ross. "U.S. companies should not be assisting in the expansion of China's...

Asian stocks fall as China reacts to US tariffs

Sep 19, 2018

SINGAPORE — Asian shares fell on Wednesday as China delayed issuing licenses to American businesses hoping to operate in the country, as the threat of more trade tariffs from Washington loomed. The approach of Hurricane Florence on the East Coast and upcoming sanctions on Iran's energy industry lifted oil prices. Benchmark U.S crude surged past $70 a barrel. KEEPING SCORE: Japan's benchmark Nikkei 225 lost 0.4 percent to 22,571.76, and the Kospi in South Korea fell 0.2 percent to 2,279.70. Hong Kong's Hang Seng index was 0.2 percent lower at 26,372.02. The Shanghai Composite index fell 0.3 percent to 2,656.26....

Sign up now!